Leadless pacemakers are miniaturized devices implanted directly into the heart and do not require wires or incisional access. The devices used in the trial include a leadless pacemaker for the right ventricle and one for the right atrium, which are designed to communicate with each other to provide the patient with beat-by-beat communication.
“This has potential to offer patients requiring pacing support not only a less invasive option, but it also eliminates lead-related complications and possibly creates a more targeted approach,” Daniel Cantillon, MD, research director and associate section head of cardiac electrophysiology and pacing in the Heart, Vascular & Thoracic Institute at Cleveland Clinic, said in a news reease from the system.
“Until now, pacemakers have only been able to pace one chamber at a time. This new system allows electrical signals to be sent to both sets of the contracting muscles to help provide the needed pacing,” Dr. Cantillon stated.
Leave a Reply